A dose increased once-weekly bortezomib-based combination therapy for multiple myeloma

Por Wei, Daolin, Tong, Yin, Bai, Haitao, Cai, Qi, Gao, Yanrong, Wang, Chun
Publicado no Oncotarget (2016)

Rituximab and Fludarabine or Cyclophosphamide Combination Treatment for Older Waldenström Macroglobulinemia Patients

Por Xu, XiaoWei, Wang, Chun, Wang, YaMin, Zhou, LiLi, Bai, HaiTao
Publicado em 2013

Complex oncogene dependence in microRNA-125a–induced myeloproliferative neoplasms

Por Guo, Shangqin, Bai, Haitao, Megyola, Cynthia M., Halene, Stephanie, Krause, Diane S., Scadden, David T., Lu, Jun
Publicado em 2012

Early tapering of immunosuppressive agents after HLA-matched donor transplantation can improve the survival of patients with advanced acute myeloid leukemia

Por Yang, Jun, Cai, Yu, Jiang, JieLing, Wan, LiPing, Bai, HaiTao, Zhu, Jun, li, Su, Wang, Chun, Song, Xianmin
Publicado no Ann Hematol (2017)

An In Vivo Functional Screen Uncovers miR-150-Mediated Regulation of Hematopoietic Injury Response

Por Adams, Brian D., Guo, Shangqin, Bai, Haitao, Guo, Yanwen, Megyola, Cynthia, Cheng, Jijun, Heydari, Kartoosh, Xiao, Changchun, Reddy, E. Premkumar, Lu, Jun
Publicado em 2012

CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2/p27(kip1) signaling

Por Zhang, Feifei, Liu, Xiaoye, Chen, Chiqi, Zhu, Jun, Yu, Zhuo, Xie, Jingjing, Xie, Li, Bai, Haitao, Zhang, Yaping, Fang, Xia, Gu, Hao, Wang, Chun, Weng, Wei, Zhang, Cheng Cheng, Chen, Guo-Qiang, Liang, Aibing, Zheng, Junke
Publicado no Haematologica (2017)

JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling

Por Zhang, Yaping, Xia, Fangzhen, Liu, Xiaoye, Yu, Zhuo, Xie, Li, Liu, Ligen, Chen, Chiqi, Jiang, Haishan, Hao, Xiaoxin, He, Xiaoxiao, Zhang, Feifei, Gu, Hao, Zhu, Jun, Bai, Haitao, Zhang, Cheng Cheng, Chen, Guo-Qiang, Zheng, Junke
Publicado no J Clin Invest (2018)